» Articles » PMID: 24075898

High Molecular Weight Complex Analysis of Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1): Structural Insights into LMP-1's Homo-oligomerization and Lipid Raft Association

Overview
Journal Virus Res
Specialty Microbiology
Date 2013 Oct 1
PMID 24075898
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

LMP-1 is a constitutively active Tumor Necrosis Factor Receptor analog encoded by Epstein-Barr virus. LMP-1 activation correlates with oligomerization and raft localization, but direct evidence of LMP-1 oligomers is limited. We report that LMP-1 forms multiple high molecular weight native LMP-1 complexes when analyzed by BN-PAGE, the largest of which are enriched in detergent resistant membranes. The largest of these high molecular weight complexes are not formed by purified LMP-1 or by loss of function LMP-1 mutants. Consistent with these results we find a dimeric form of LMP-1 that can be stabilized by disulfide crosslinking. We identify cysteine 238 in the C-terminus of LMP-1 as the crosslinked cysteine. Disulfide crosslinking occurs post-lysis but the dimer can be crosslinked in intact cells with membrane permeable crosslinkers. LMP-1/C238A retains wild type LMP-1 NF-κB activity. LMP-1's TRAF binding, raft association and oligomerization are associated with the dimeric form of LMP-1. Our results suggest the possibility that the observed dimeric species results from inter-oligomeric crosslinking of LMP-1 molecules in adjacent core LMP-1 oligomers.

Citing Articles

In Silico Modeling and Characterization of Epstein-Barr Virus Latent Membrane Protein 1 Protein.

Salam D, Gunasinghe K, Hwang S, Ginjom I, Chee Wezen X, Rahman T ACS Omega. 2024; 9(50):49422-49431.

PMID: 39713625 PMC: 11656244. DOI: 10.1021/acsomega.4c06868.


The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets.

Cheerathodi M, Meckes Jr D Future Virol. 2021; 13(12):863-887.

PMID: 34079586 PMC: 8168621. DOI: 10.2217/fvl-2018-0120.

References
1.
Sandberg M, Hammerschmidt W, Sugden B . Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol. 1997; 71(6):4649-56. PMC: 191686. DOI: 10.1128/JVI.71.6.4649-4656.1997. View

2.
Erickson K, Martin J . The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling. J Virol. 2000; 74(2):1057-60. PMC: 111632. DOI: 10.1128/jvi.74.2.1057-1060.2000. View

3.
Balaji V, Mobasser A, Rao S . Modification of protein stability by introduction of disulfide bridges and prolines: geometric criteria for mutation sites. Biochem Biophys Res Commun. 1989; 160(1):109-14. DOI: 10.1016/0006-291x(89)91627-6. View

4.
Siegel R, Chan F, Chun H, Lenardo M . The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol. 2001; 1(6):469-74. DOI: 10.1038/82712. View

5.
Reyes-Moreno C, Girouard J, Lapointe R, Darveau A, Mourad W . CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J Biol Chem. 2003; 279(9):7799-806. DOI: 10.1074/jbc.M313168200. View